Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Science of MDHAQ/RAPID3 Scores

Theodore Pincus, MD  |  Issue: December 2011  |  December 12, 2011

click for large version
Figure 3: 9–10-year survival according to quantitative markers in three chronic diseases.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
click for large version
Figure 4: Time to score RA measures (in seconds).

A Closer Look at Development of the MDHAQ/RAPID3

Evolution of a two-sided, one-page MDHAQ continued as one of the few questionnaires developed in actual clinical (rather than research) settings to improve care (see Table 1)—although much research data emerged.6 In 1995, it was recognized that improved patient status led to “floor effects” on the HAQ and MHAQ, i.e., scores of zero although patients nonetheless had functional limitations. Therefore, queries concerning complex activities were added—initially six and ultimately two: “walk two miles or three kilometers” and “participate in sports and recreation as you would like” (see Figure 1).7,8 Queries concerning sleep, anxiety, and depression were added, scores of which are as high or higher than for most traditional HAQ items.8 Visual analog scales (VAS) for pain and global status were converted from a 10-cm line to 21 circles (in increments of 0.5) (see Figure 1), so that a ruler is no longer required for scoring.12

Scoring templates were developed for Routine Assessment of Patient Index Data (RAPID)3, a simple 0–30 composite of three 0–10 scores for physical function, pain and patient global estimate, the 3 RA Core Data Set measures.13,14 A self-report joint count was added from the Rheumatoid Arthritis Disease Activity Index (RADAI) questionnaire.15 RADAI and the psychological status queries were scored formally in earlier versions, as RAPID4 and RAPID5, but RAPID3 scores gave similar information in much less time.13 Therefore, formal scoring of these scales is no longer advocated, though the scales provide highly useful clinical information.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The second page of the MDHAQ (see Figure 2) includes a review of systems and recent medical history. More than 25 checks for positive symptoms is characteristic of patients with fibromyalgia, some of whom may also meet criteria for diseases such as RA or SLE; this information proves quite helpful as a clue that symptoms may be due to fibromyalgia rather than inflammation, a difficult determination in some patients.16 A recent medical history summary can save at least two to three minutes for the doctor if all answers are “no,” whereas any “yes” responses should be known.17 Queries concerning change in status, exercise, a visual analog scale for fatigue, demographic measures, consent for further monitoring, and contact in the future should the patient change clinical settings also have proven their value over and over.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:Diagnostic Criteriaevidence-based medicineHealth Assessment Questionnairepatient carerheumatology

Related Articles

    Remote Use of the Multidimensional Health Assessment Questionnaire (MDHAQ)

    December 18, 2019

    The patient medical history is far more prominent in clinical decisions for rheumatology than for many common chronic diseases in which a gold standard biomarker, such as blood pressure or serum glucose, is applicable to diagnosis and management of all individual patients.1 Components of a subjective patient history may be recorded as structured, quantitative, standard,…

    The Peripatetitc Theodore Pincus, MD

    July 1, 2007

    Tireless champion for patient self-report

    Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

    April 1, 2013

     Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

    Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate

    March 1, 2015

    Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences